1
|
Nelson EV, Ross SJ, Olejnik J, Hume AJ, Deeney DJ, King E, Grimins AO, Lyons SM, Cifuentes D, Mühlberger E. The 3' Untranslated Regions of Ebola Virus mRNAs Contain AU-Rich Elements Involved in Posttranscriptional Stabilization and Decay. J Infect Dis 2023; 228:S488-S497. [PMID: 37551415 PMCID: PMC10651315 DOI: 10.1093/infdis/jiad312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Revised: 07/29/2023] [Accepted: 08/01/2023] [Indexed: 08/09/2023] Open
Abstract
The 3' untranslated regions (UTRs) of Ebola virus (EBOV) mRNAs are enriched in their AU content and therefore represent potential targets for RNA binding proteins targeting AU-rich elements (ARE-BPs). ARE-BPs are known to fine-tune RNA turnover and translational activity. We identified putative AREs within EBOV mRNA 3' UTRs and assessed whether they might modulate mRNA stability. Using mammalian and zebrafish embryo reporter assays, we show a conserved, ARE-BP-mediated stabilizing effect and increased reporter activity with the tested EBOV 3' UTRs. When coexpressed with the prototypic ARE-BP tristetraprolin (TTP, ZFP36) that mainly destabilizes its target mRNAs, the EBOV nucleoprotein (NP) 3' UTR resulted in decreased reporter gene activity. Coexpression of NP with TTP led to reduced NP protein expression and diminished EBOV minigenome activity. In conclusion, the enrichment of AU residues in EBOV 3' UTRs makes them possible targets for cellular ARE-BPs, leading to modulation of RNA stability and translational activity.
Collapse
Affiliation(s)
- Emily V Nelson
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Stephen J Ross
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA
- Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Judith Olejnik
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA
| | - Adam J Hume
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA
| | - Dylan J Deeney
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA
| | - Emily King
- Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Autumn O Grimins
- Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Shawn M Lyons
- Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Daniel Cifuentes
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
| | - Elke Mühlberger
- Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA
| |
Collapse
|
2
|
Cross RW, Longini IM, Becker S, Bok K, Boucher D, Carroll MW, Díaz JV, Dowling WE, Draghia-Akli R, Duworko JT, Dye JM, Egan MA, Fast P, Finan A, Finch C, Fleming TR, Fusco J, Geisbert TW, Griffiths A, Günther S, Hensley LE, Honko A, Hunegnaw R, Jakubik J, Ledgerwood J, Luhn K, Matassov D, Meshulam J, Nelson EV, Parks CL, Rustomjee R, Safronetz D, Schwartz LM, Smith D, Smock P, Sow Y, Spiropoulou CF, Sullivan NJ, Warfield KL, Wolfe D, Woolsey C, Zahn R, Henao-Restrepo AM, Muñoz-Fontela C, Marzi A. An introduction to the Marburg virus vaccine consortium, MARVAC. PLoS Pathog 2022; 18:e1010805. [PMID: 36227853 PMCID: PMC9560149 DOI: 10.1371/journal.ppat.1010805] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of the MARV vaccine "MARVAC" consortium representing leaders in the field of vaccine research and development aiming to facilitate a rapid response to this infectious disease threat. Here, we discuss current progress, challenges, and future directions for MARV vaccines.
Collapse
Affiliation(s)
- Robert W. Cross
- Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Ira M. Longini
- Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America
| | - Stephan Becker
- Institute for Virology, Philipps-Universität Marburg, Marburg, Germany
| | - Karin Bok
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
| | - David Boucher
- U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America
| | - Miles W. Carroll
- Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom
| | | | - William E. Dowling
- Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America
| | - Ruxandra Draghia-Akli
- Johnson & Johnson—Global Public Health Research and Development, Spring House, Pennsylvania, United States of America
| | - James T. Duworko
- Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia
| | - John M. Dye
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
| | - Michael A. Egan
- Auro Vaccines, Pearl River, New York, United States of America
| | | | - Amy Finan
- Sabin vaccine Institute, Washington, DC, United States of America
| | - Courtney Finch
- Sabin vaccine Institute, Washington, DC, United States of America
| | - Thomas R. Fleming
- University of Washington, Seattle, Washington, United States of America
| | - Joan Fusco
- Public Health Vaccines, Cambridge, Massachusetts, United States of America
| | - Thomas W. Geisbert
- Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Anthony Griffiths
- National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America
| | - Stephan Günther
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Lisa E. Hensley
- Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America
| | - Anna Honko
- National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America
| | - Ruth Hunegnaw
- Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
| | - Jocelyn Jakubik
- Sabin vaccine Institute, Washington, DC, United States of America
| | - Julie Ledgerwood
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
| | - Kerstin Luhn
- Janssen Vaccines & Prevention, Leiden, the Netherlands
| | | | | | - Emily V. Nelson
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | - Roxana Rustomjee
- Sabin vaccine Institute, Washington, DC, United States of America
| | - David Safronetz
- Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | | | - Dean Smith
- Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Paul Smock
- Sabin vaccine Institute, Washington, DC, United States of America
| | - Ydrissa Sow
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
| | - Christina F. Spiropoulou
- Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Nancy J. Sullivan
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
| | - Kelly L. Warfield
- Emergent BioSolutions, Gaithersburg, Maryland, United States of America
| | - Daniel Wolfe
- Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Courtney Woolsey
- Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Roland Zahn
- Janssen Vaccines & Prevention, Leiden, the Netherlands
| | | | | | - Andrea Marzi
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
| |
Collapse
|
3
|
Koundouno FR, Kafetzopoulou LE, Faye M, Renevey A, Soropogui B, Ifono K, Nelson EV, Kamano AA, Tolno C, Annibaldis G, Millimono SL, Camara J, Kourouma K, Doré A, Millimouno TE, Tolno FMB, Hinzmann J, Soubrier H, Hinrichs M, Thielebein A, Herzer G, Pahlmann M, Ki-Zerbo GA, Formenty P, Legand A, Wiley MR, Faye O, Diagne MM, Sall AA, Lemey P, Bah A, Günther S, Keita S, Duraffour S, Magassouba N. Detection of Marburg Virus Disease in Guinea. N Engl J Med 2022; 386:2528-2530. [PMID: 35767445 PMCID: PMC7613962 DOI: 10.1056/nejmc2120183] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Fara R Koundouno
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | | | - Annick Renevey
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | - Kékoura Ifono
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Emily V Nelson
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Aly A Kamano
- World Health Organization Guinea, Conakry, Guinea
| | | | | | - Saa L Millimono
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | - Karifa Kourouma
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | | | | | - Julia Hinzmann
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Hugo Soubrier
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Mette Hinrichs
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Anke Thielebein
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Glaucia Herzer
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Meike Pahlmann
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | | | | | | | | | | | | | | | | | | | - Stephan Günther
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Sakoba Keita
- Agence Nationale de Sécurité Sanitaire, Conakry, Guinea
| | - Sophie Duraffour
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - N'Faly Magassouba
- Laboratoire des Fièvres Hémorragiques Virales de Guinée, Conakry, Guinea
| |
Collapse
|
4
|
Vairo F, Aimè Coussoud-Mavoungou MP, Ntoumi F, Castilletti C, Kitembo L, Haider N, Carletti F, Colavita F, Gruber CEM, Iannetta M, Messina F, Lanini S, Ulrich Judicaël B, Giombini E, Montaldo C, Portella C, Diafouka-Diatela S, Rueca M, Kock R, Bartolini B, Mboera L, Munster V, Fischer R, Seifert S, Muñoz-Fontela C, Escudero-Pérez B, Gomez-Medina S, Nelson EV, Kjia Tungu P, Nicastri E, Puro V, Di Caro A, Capobianchi MR, Mikolo JL, Zumla A, Ippolito G. Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation. Viruses 2020; 12:v12091020. [PMID: 32933109 PMCID: PMC7551106 DOI: 10.3390/v12091020] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 09/08/2020] [Accepted: 09/10/2020] [Indexed: 02/07/2023] Open
Abstract
The Republic of Congo (RoC) declared a chikungunya (CHIK) outbreak on 9 February 2019. We conducted a ONE-Human-Animal HEALTH epidemiological, virological and entomological investigation. Methods: We collected national surveillance and epidemiological data. CHIK diagnosis was based on RT-PCR and CHIKV-specific antibodies. Full CHIKV genome sequences were obtained by Sanger and MinION approaches and Bayesian tree phylogenetic analysis was performed. Mosquito larvae and 215 adult mosquitoes were collected in different villages of Kouilou and Pointe-Noire districts and estimates of Aedes (Ae.) mosquitos' CHIKV-infectious bites obtained. We found two new CHIKV sequences of the East/Central/South African (ECSA) lineage, clustering with the recent enzootic sub-clade 2, showing the A226V mutation. The RoC 2019 CHIKV strain has two novel mutations, E2-T126M and E2-H351N. Phylogenetic suggests a common origin from 2016 Angola strain, from which it diverged around 1989 (95% HPD 1985-1994). The infectious bite pattern was similar for 2017, 2018 and early 2019. One Ae. albopictus pool was RT-PCR positive. The 2019 RoC CHIKV strain seems to be recently introduced or be endemic in sylvatic cycle. Distinct from the contemporary Indian CHIKV isolates and in contrast to the original Central-African strains (transmitted by Ae. aegypti), it carries the A226V mutation, indicating an independent adaptive mutation in response to vector replacement (Ae. albopictus vs Ae. aegypti).
Collapse
Affiliation(s)
- Francesco Vairo
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | | | - Francine Ntoumi
- Ministry of Science and Technology, Brazzaville CG-BZV, Congo
- University Marien Ngouabi, Brazzaville CG-BZV, Congo
- Institute for Tropical Medicine, University of Tübingen, 72074 Tübingen, Germany;
- Correspondence: (F.N.); (G.I.)
| | - Concetta Castilletti
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Lambert Kitembo
- Ministry of Public Health, Brazzaville CG-BZV, Congo; (L.K.); (B.U.J.); (J.L.M.)
| | - Najmul Haider
- The Royal Veterinary College, University of London, Hawkshead Lane, Hertfordshire NW1 0TU, UK; (N.H.); (R.K.)
| | - Fabrizio Carletti
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Francesca Colavita
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Cesare E. M. Gruber
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Marco Iannetta
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Francesco Messina
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Simone Lanini
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Biez Ulrich Judicaël
- Ministry of Public Health, Brazzaville CG-BZV, Congo; (L.K.); (B.U.J.); (J.L.M.)
| | - Emanuela Giombini
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Chiara Montaldo
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | | | | | - Martina Rueca
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Richard Kock
- The Royal Veterinary College, University of London, Hawkshead Lane, Hertfordshire NW1 0TU, UK; (N.H.); (R.K.)
| | - Barbara Bartolini
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Leonard Mboera
- SACIDS Foundation for One Health, Sokoine University of Agriculture, Morogoro 30007, Tanzania;
| | - Vincent Munster
- Virus Ecology Unit, Laboratory of Virology, Rocky Mountain Laboratories, NIAID/NIH, Bethesda, MD 20814, USA; (V.M.); (R.F.); (S.S.)
| | - Robert Fischer
- Virus Ecology Unit, Laboratory of Virology, Rocky Mountain Laboratories, NIAID/NIH, Bethesda, MD 20814, USA; (V.M.); (R.F.); (S.S.)
| | - Stephanie Seifert
- Virus Ecology Unit, Laboratory of Virology, Rocky Mountain Laboratories, NIAID/NIH, Bethesda, MD 20814, USA; (V.M.); (R.F.); (S.S.)
| | - César Muñoz-Fontela
- Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse, D-20359 Hamburg, Germany; (C.M.-F.); (B.E.-P.); (S.G.-M.); (E.V.N.)
- German Center for Infection Research (DZIF), Partner Site Hamburg, 38124 Hamburg, Germany
| | - Beatriz Escudero-Pérez
- Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse, D-20359 Hamburg, Germany; (C.M.-F.); (B.E.-P.); (S.G.-M.); (E.V.N.)
| | - Sergio Gomez-Medina
- Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse, D-20359 Hamburg, Germany; (C.M.-F.); (B.E.-P.); (S.G.-M.); (E.V.N.)
| | - Emily V. Nelson
- Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse, D-20359 Hamburg, Germany; (C.M.-F.); (B.E.-P.); (S.G.-M.); (E.V.N.)
| | | | - Emanuele Nicastri
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Vincenzo Puro
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Antonino Di Caro
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Maria Rosaria Capobianchi
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
| | - Jacqueline Lydia Mikolo
- Ministry of Public Health, Brazzaville CG-BZV, Congo; (L.K.); (B.U.J.); (J.L.M.)
- Laboratoire National de la Santè Publique, Brazzaville CG-BZV, Congo
| | - Alimuddin Zumla
- Division of Infection and Immunity, Center for Clinical Microbiology, University College London, London WC1E 6BT, UK;
- National Institute of Health Research Biomedical Research Centre at UCL Hospitals, London W1T 7HA, UK
| | - Giuseppe Ippolito
- National Institute for Infectious Diseases ‘Lazzaro Spallanzani’, IRCCS, 00149 Rome, Italy; (F.V.); (C.C.); (F.C.); (F.C.); (C.E.M.G.); (M.I.); (F.M.); (S.L.); (E.G.); (C.M.); (M.R.); (B.B.); (E.N.); (V.P.); (A.D.C.); (M.R.C.)
- Correspondence: (F.N.); (G.I.)
| | | |
Collapse
|
5
|
Escudero-Pérez B, Ruibal P, Rottstegge M, Lüdtke A, Port JR, Hartmann K, Gómez-Medina S, Müller-Guhl J, Nelson EV, Krasemann S, Rodríguez E, Muñoz-Fontela C. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice. JCI Insight 2019; 4:126070. [PMID: 31550241 PMCID: PMC6948759 DOI: 10.1172/jci.insight.126070] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2018] [Accepted: 09/19/2019] [Indexed: 01/14/2023] Open
Abstract
Filoviruses of the genus Ebolavirus include 6 species with marked differences in their ability to cause disease in humans. From the highly virulent Ebola virus to the seemingly nonpathogenic Reston virus, case fatality rates can range between 0% and 90%. In order to understand the molecular basis of these differences, it is imperative to establish disease models that recapitulate human disease as faithfully as possible. Nonhuman primates (NHPs) are the gold-standard models for filovirus pathogenesis, but comparative studies are skewed by the fact that Reston virus infection can be lethal for NHPs. Here we used HLA-A2-transgenic, NOD-scid-IL-2γ receptor-knockout (NSG-A2) mice reconstituted with human hematopoiesis to compare Ebola virus and Reston virus pathogenesis in a human-like environment. While markedly less pathogenic than Ebola virus, Reston virus killed 20% of infected mice, a finding that was linked to exacerbated inflammation and viral replication in the liver. In addition, the case fatality ratios of different Ebolavirus species in humans were recapitulated in the humanized mice. Our findings point to humanized mice as a putative model to test the pathogenicity of newly discovered filoviruses, and suggest that further investigations on Reston virus pathogenesis in humans are warranted.
Collapse
Affiliation(s)
- Beatriz Escudero-Pérez
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| | - Paula Ruibal
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Monika Rottstegge
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| | - Anja Lüdtke
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - Julia R Port
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| | - Kristin Hartmann
- Institute for Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Sergio Gómez-Medina
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| | - Jürgen Müller-Guhl
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| | - Emily V Nelson
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| | - Susanne Krasemann
- Institute for Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Estefanía Rodríguez
- Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| | - César Muñoz-Fontela
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.,German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
| |
Collapse
|
6
|
Nelson EV, Fairweather ML, Ashiglar SM, Hanna JW, Klopfenstein NB. First Report of the Armillaria Root Disease Pathogen, Armillaria gallica, on Douglas-fir (Pseudotsuga menziesii) in Arizona. Plant Dis 2013; 97:1658. [PMID: 30716834 DOI: 10.1094/pdis-04-13-0450-pdn] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
In August 2010, a mycelial fan (isolate AZ32F) of Armillaria sp. was collected from the root collar of a living Douglas-fir tree on the Mogollon Rim within the Coconino National Forest (approximate location 34°25'31.26″N, 111°20'41.04″W, elevation 2,293 m) in central Arizona. Mycelial fans under the bark of living trees are a sign of pathogenicity, and symptoms of the diseased tree included resinosis, sloughing bark, and thinning crown. The infected tree was located on a south-facing slope with approximately 30% tree cover, dominated by ponderosa pine (Pinus ponderosa), with lesser components of Douglas-fir and Gambel oak (Quercus gambelii). Based on three replications of somatic incompatibility tests against 24 tester isolates representing seven North American Armillaria spp., isolate AZ32F showed 100% intraspecific compatibility (colorless antagonism) with all four A. gallica isolates, 22% compatibility with A. calvescens, and 0% compatibility with the remaining Armillaria spp. Based on GenBank BLASTn of isolate AZ32F sequences, the partial LSU-IGS1 (GenBank Accession No. KF186682) showed 99 to 100% similarity to A. gallica and two other related Armillaria spp. with 99 to 100% coverage, and translation elongation factor-1 alpha (tef-1α) sequences (KC525954) showed 96% similarity to A. gallica (JF895844) with 100% coverage. Thus, isolate AZ32F was identified as A. gallica, based on somatic incompatibility tests and DNA sequences (partial LSU-IGS1 and tef-1α). Although the isolate is identified as A. gallica with similarities to other North American isolates, evidence is mounting that currently recognized A. gallica likely represents a species complex that comprises multiple phylogenetic species (4). Previous surveys in Arizona have noted A. mellea and A. solidipes (as A. ostoyae) (3), but A. gallica has never been previously confirmed in this state. Within North America, A. gallica is commonly reported east of the Rocky Mountains and in West Coast states of the United States, where it infects hardwoods and conifers including Douglas-fir (1,2). Its ecological behavior ranges from saprophyte to weak/aggressive pathogen (1,2). Because damage by A. gallica appears to increase on hosts predisposed by stress (1), further surveys are needed to document its distribution, frequency, and ecological behavior in the southwestern United States, where climate change will likely cause tree stress due to maladaptation. Continued surveys for Armillaria spp. will better determine their potential threat within the geologically and ecologically unique Mogollon Rim of Arizona. References: (1) K. Baumgartner and D. M. Rizzo. Plant Dis. 85:947, 2001. (2) N. J. Brazee and R. L. Wick. For. Ecol. Manage. 258:1605, 2009. (3) R. L. Gilbertson and D. M. Bigelow. J. Arizona-Nevada Acad. Sci. 31:13, 1998. (4) M.-S. Kim et al. Phytopathology 102:S4.63, 2012.
Collapse
Affiliation(s)
- E V Nelson
- School of Forestry, Northern Arizona University, 200 East Pine Knoll Drive, Flagstaff 86011
| | - M L Fairweather
- USDA Forest Service, Forest Health Protection, Region 3, 2500 South Pine Knoll Drive Flagstaff, AZ 86001
| | - S M Ashiglar
- USDA Forest Service, Rocky Mountain Research Station, Forestry Sciences Laboratory, 1221 South Main Street, Moscow, ID 83843
| | - J W Hanna
- USDA Forest Service, Rocky Mountain Research Station, Forestry Sciences Laboratory, 1221 South Main Street, Moscow, ID 83843
| | - N B Klopfenstein
- USDA Forest Service, Rocky Mountain Research Station, Forestry Sciences Laboratory, 1221 South Main Street, Moscow, ID 83843
| |
Collapse
|
7
|
Abstract
Elytra of the bessbeetle, Odontotaenius disjunctus were thin sectioned after embedding in epoxy resin. Sections were cut with a diamond saw, ground to the desired thickness on a rotary grinder and polished. Tearing and distortion were reduced when compared to knifecut sections of heavily sclerotized cuticle.
Collapse
Affiliation(s)
- J W Sawvel
- Dept. of Biological Sciences, Ohio Northern University, Ada 45810
| | | | | | | |
Collapse
|
8
|
|